Stability Assessment of Pharmaceutical Products Under Accelerated Conditions

Abstract

An essential aspect of developing a pharmaceutical product is performing a stability assessment to ensure that the drug will be safe, effective, and perform as expected during its shelf life. To help predict long-term stability of pharmaceutical products, accelerated stability studies are frequently used by placing drug products under high temperature and humidity conditions for a predetermined period of time. The objective of the study was to evaluate the stability of pharmaceutical products stored under accelerated conditions in accordance with the International Council for Harmonisation (ICH) guidelines. Representative batches of the formulation were put into the appropriate container-closure system and stored at 40 ± 2 degrees Celsius and 75 ± 5 percent relative humidity (RH) for six months. Samples of the products were taken from the test conditions at pre-specified time points and analyzed for critical physical and chemical properties such as appearance, assay, dissolution, moisture content, pH, hardness, friability, and impurity profile. Based on the analysis results, all formulations remained within acceptable pharmacopoeial specifications for the duration of the study with minimal variations observed in physicochemical properties. The lack of significant degradation of the products or change in potency indicates sufficient stability at accelerated conditions. Accelerated stability studies yield useful information about predicted shelf-life, required storage conditions and suitability of packaging for pharmaceutical products. Furthermore, accelerated stability studies are important tools in providing quality assurance and regulatory compliance for developing stable and effective pharmaceutical formulations with predictable long-term performance.